Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Status:
Withdrawn
Trial end date:
1999-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Biological therapies use different ways to stimulate the immune
system and stop cancer cell from growing. Combining more than one chemotherapy drug with
biological therapy may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, isotretinoin,
and interferon alfa in treating patients who have acute myelogenous leukemia.